N.M. Admin. Code § 16.22.22.8

Current through Register Vol. 35, No. 21, November 5, 2024

Section 16.22.22.8 - PSYCHOPHARMACOLOGY (RxP) APPLICATION COMMITTEE

A. The chair of the board may appoint one or more RxP application committee(s) to review application(s) for conditional prescription and prescription certificates and to make recommendations to the board.

B. The RxP application committee will consist of a minimum of three members who shall reside in New Mexico and who shall hold active, unrestricted New Mexico licenses in their respective profession. The committee shall consist of:

(1) one person appointed by the chair of the board who is experienced in psychopharmacology;

(2) one person appointed by the chair of the board, in collaboration with the New Mexico medical board, who is an allopathic or osteopathic physician or a nurse practitioner or physicians assistant with clinical experience in mental health or psychopharmacology.

C. Members of the RxP application committee shall not be in a psychopharmacology training program, and shall not be seeking licensure as a psychologist.

D. Members of the RxP application committee shall not participate in the review, deliberation, or decision of an application if the applicant is a member of the member's family or household or if the member has a conflict of interest as defined in 16.22.25 NMAC, of these regulations.

E. The New Mexico medical board or its designee shall be available upon request to consult with the RxP application committee or the board regarding the applicability of the regulations adopted pursuant to Section 61-9-17.1 NMSA 1978 of the act to a particular application.

F. The RxP application committee shall provide the board a recommendation to accept or reject an application for a conditional prescription or prescription certificate. A recommendation to reject an application shall state the reasons for the recommendation.

N.M. Admin. Code § 16.22.22.8

16.22.22.8 NMAC - Rp, 16.22.22.8 NMAC, 11/15/06, Amended by New Mexico Register, Volume XXXV, Issue 19, October 8, 2024, eff. 10/8/2024